Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Aligos Therapeutics
Biotech
As Madrigal lands MASH nod, what's next for biotechs in pursuit?
Madrigal’s MASH drug has been approved. For the other companies with up-and-coming treatments trailing in the clinic, the question is: What now?
Annalee Armstrong
Mar 15, 2024 10:55am
Hepatitis B drug developers chart slow progress, just like hep C
Nov 14, 2023 9:05am
Aligos culls another hep B asset over inconclusive efficacy data
Aug 4, 2023 7:27am
Gilead expands Arcus oncology pact into inflammatory disease
May 15, 2023 11:31am
Aligos' cash crunch and layoffs force focus on NASH, COVID-19
Feb 9, 2023 7:30am
Aligos demands jury trial to settle Janssen theft allegations
Sep 29, 2022 11:20am
